7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 
      
    		                    
      assets
    		                    
      current assets:
    		                    
      cash and cash equivalents
    		243,574,000 269,907,000 285,053,000 322,399,000 578,157,000 573,171,000 561,691,000 574,962,000 579,605,000 580,176,000           
      accounts receivable
    		22,537,000 27,882,000 28,493,000 38,520,000 28,873,000 38,651,000 36,685,000 54,605,000 45,674,000 48,987,000 56,273,000 138,624,000 114,069,000 120,354,000 120,355,000 117,512,000 65,939,000 83,534,000 121,821,000 51,018,000 
      inventory
    		45,326,000 46,667,000 49,773,000 50,082,000 50,409,000 49,294,000 49,846,000 51,397,000 49,142,000 47,402,000 54,819,000 43,152,000 62,424,000 60,113,000 51,409,000 51,557,000 56,246,000 47,781,000 47,129,000 33,301,000 
      prepaid expenses and other current assets
    		14,430,000 15,305,000 12,963,000 18,145,000 21,659,000 17,063,000 16,818,000 17,830,000 22,916,000 22,515,000 25,532,000 25,798,000 23,432,000 19,664,000 15,902,000 19,698,000 17,395,000 13,432,000 8,918,000 11,095,000 
      total current assets
    		325,867,000 359,761,000 376,282,000 429,146,000 679,098,000 685,362,000 667,884,000 699,912,000 700,865,000 699,312,000 765,513,000 847,902,000 835,526,000 759,382,000 619,135,000 740,039,000 687,478,000 644,491,000 425,543,000 331,598,000 
      property and equipment
    		158,624,000 162,727,000 166,428,000 164,474,000 164,555,000 165,503,000 161,628,000 162,900,000 153,565,000 141,619,000 87,721,000 52,694,000 48,420,000 46,956,000 47,702,000 46,332,000 108,322,000 104,751,000 105,133,000 101,305,000 
      goodwill
    		129,429,000 129,429,000 159,878,000 159,878,000 171,790,000 326,029,000 326,029,000 326,029,000 326,029,000 326,459,000 326,569,000 283,668,000 283,535,000 283,535,000 283,535,000 152,766,000 152,766,000 152,766,000 224,275,000 224,275,000 
      intangible assets
    		185,876,000 193,066,000 199,581,000 194,957,000 201,858,000 207,249,000 214,118,000 220,987,000 227,856,000 234,726,000 241,578,000 216,663,000 222,899,000 229,153,000 235,405,000 117,571,000 121,225,000 125,116,000 172,616,000 177,656,000 
      other assets
    		49,395,000 51,983,000 57,582,000 59,789,000 60,914,000 63,465,000 74,982,000 77,622,000 85,579,000 92,735,000 127,035,000 115,589,000 87,399,000 72,419,000 64,243,000 53,451,000 4,106,000 4,026,000 4,300,000 4,158,000 
      total assets
    		849,191,000 896,966,000 959,751,000 1,008,244,000 1,278,215,000 1,447,608,000 1,444,641,000 1,487,450,000 2,267,553,000 2,264,437,000 2,315,388,000 2,282,315,000 2,248,899,000 2,171,799,000 2,043,230,000 1,918,276,000 1,894,683,000 1,601,247,000 1,351,768,000 1,270,691,000 
      liabilities and stockholders’ equity
    		                    
      current liabilities:
    		                    
      accounts payable
    		7,998,000 11,525,000 9,525,000 11,957,000 9,494,000 12,536,000 8,226,000 10,729,000 9,424,000 6,658,000 4,784,000 5,991,000 9,459,000 23,267,000 10,384,000 8,154,000 8,917,000 11,704,000 9,806,000 8,171,000 
      accrued expenses and other current liabilities
    		48,136,000 50,202,000 44,603,000 36,407,000 38,498,000 40,719,000 35,405,000 60,237,000 56,042,000 50,344,000 70,065,000 53,371,000 60,187,000 43,641,000 32,411,000 34,574,000 31,422,000 24,794,000 28,973,000 38,546,000 
      current portion of long-term debt
    		5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 5,440,000 6,000,000 6,000,000 6,000,000 6,000,000 6,000,000 
      total current liabilities
    		61,574,000 69,682,000 63,158,000 56,971,000 63,241,000 68,552,000 59,022,000 87,468,000 78,253,000 74,919,000 124,896,000 110,144,000 115,655,000 112,530,000 86,675,000 93,777,000 114,352,000 164,773,000 165,252,000 130,778,000 
      long-term debt, less current portion
    		287,381,000 288,436,000 289,499,000 290,492,000 516,283,000 517,083,000 517,893,000 518,707,000 519,520,000 520,336,000 521,161,000 521,997,000 522,824,000 523,655,000 524,499,000 524,591,000 525,584,000 526,583,000 527,593,000 528,614,000 
      finance lease liabilities, less current portion
    		30,407,000 30,651,000 30,881,000 31,106,000 31,327,000 31,527,000 31,714,000 31,897,000 32,077,000 32,236,000           
      other long-term liabilities
    		37,970,000 38,186,000 43,966,000 52,466,000 54,237,000 54,032,000 58,623,000 59,494,000 64,531,000 62,862,000 66,052,000 68,975,000 57,519,000 50,590,000 66,522,000 41,066,000 1,553,000 1,057,000 2,310,000 2,231,000 
      total liabilities
    		417,332,000 428,983,000 429,478,000 431,035,000 665,088,000 671,194,000 667,252,000 697,566,000 1,375,272,000 1,366,799,000 1,414,750,000 1,377,072,000 1,407,230,000 1,398,007,000 1,388,928,000 1,372,915,000 1,441,067,000 1,268,106,000 1,142,012,000 1,115,945,000 
      commitments and contingencies
    		                    
      stockholders’ equity:
    		                    
      class a common stock
    		1,447,000 1,446,000 1,440,000 1,420,000 1,416,000 1,415,000 1,327,000 1,322,000 1,319,000 1,319,000 1,318,000 1,317,000 1,315,000 1,315,000 1,315,000 1,315,000 1,314,000 1,143,000 966,000 966,000 
      class b common stock
    		1,107,000 1,107,000 1,107,000 1,107,000 1,107,000 1,107,000 1,191,000 1,191,000 1,191,000 1,191,000 1,191,000 1,237,000 1,237,000 1,237,000 1,237,000 1,237,000 1,262,000 1,433,000 1,610,000 1,610,000 
      additional paid-in capital
    		196,511,000 191,377,000 186,797,000 181,874,000 175,581,000 168,337,000 134,482,000 128,503,000 125,088,000 119,903,000 114,309,000 137,898,000 134,077,000 131,373,000 128,584,000 128,386,000 172,611,000 118,208,000 85,976,000 85,125,000 
      retained earnings
    		45,799,000 71,355,000 110,946,000 140,891,000 167,036,000 266,074,000 273,659,000 285,737,000 391,696,000 398,158,000 404,699,000 404,766,000 367,132,000 322,663,000 251,423,000 184,561,000 127,450,000 73,176,000 24,101,000 854,000 
      accumulated other comprehensive income
    		579,000 574,000 324,000                  
      total stockholders’ equity attributable to maravai lifesciences holdings, inc.
    		245,443,000 265,859,000 300,614,000 325,292,000 345,140,000 436,933,000 410,659,000 416,753,000 519,294,000 520,571,000 521,517,000 545,218,000 503,761,000        
      non-controlling interest
    		186,416,000 202,124,000 229,659,000 251,917,000 267,987,000 339,481,000 366,730,000 373,131,000 372,987,000 377,067,000 379,121,000 360,025,000 337,908,000 317,204,000 271,743,000 229,862,000 150,979,000    
      total stockholders’ equity
    		431,859,000 467,983,000 530,273,000 577,209,000 613,127,000 776,414,000 777,389,000 789,884,000 892,281,000 897,638,000 900,638,000 905,243,000 841,669,000        
      total liabilities and stockholders’ equity
    		849,191,000 896,966,000 959,751,000 1,008,244,000 1,278,215,000 1,447,608,000 1,444,641,000 1,487,450,000 2,267,553,000 2,264,437,000 2,315,388,000 2,282,315,000 2,248,899,000        
      deferred revenue
    		 1,639,000 2,756,000 2,375,000 1,834,000 2,078,000 2,210,000 3,360,000 2,553,000 2,459,000 2,053,000 3,088,000 5,822,000 5,435,000 3,693,000 10,211,000 66,715,000 109,490,000 119,175,000 78,061,000 
      current portion of finance lease liabilities
    		 876,000 834,000 792,000 750,000 710,000 672,000 633,000 596,000 560,000           
      deferred tax liabilities
    		 2,028,000 1,974,000      6,690,000 8,512,000 8,680,000        8,571,000 8,609,000 
      interest rate cap
    		     6,575,000               
      current portion of payable to related parties pursuant to the tax receivable agreement
    		    7,225,000 7,069,000 7,069,000 7,069,000 4,198,000 9,458,000 42,254,000 42,254,000 34,747,000        
      government funding receivable
    		     608,000 2,844,000 1,118,000 3,528,000 232,000 616,000 8,190,000 18,155,000 8,575,000       
      deferred tax assets
    		        773,659,000 769,586,000 766,972,000 765,799,000 771,120,000 780,354,000 793,210,000 808,117,000 820,786,000 570,097,000 419,901,000 431,699,000 
      payable to related parties pursuant to the tax receivable agreement, less current portion
    		        674,201,000 667,934,000 677,392,000 675,956,000 711,232,000        
      cash
    		          628,273,000 632,138,000 617,446,000 550,676,000 431,469,000 551,272,000 547,898,000 374,710,000 247,675,000 236,184,000 
      current portion of finance lease obligations
    		          300,000          
      finance lease obligations, less current portion
    		          16,569,000          
      liabilities and stockholders' equity
    		                    
      current portion of payable to related parties pursuant to a tax receivable agreement
    		             34,747,000 34,747,000 34,838,000 1,298,000 1,298,000   
      payable to related parties pursuant to a tax receivable agreement, less current portion
    		             711,232,000 711,232,000 713,481,000     
      stockholders' equity:
    		                    
      total stockholders' equity attributable to maravai lifesciences holdings, inc.
    		             456,588,000 382,559,000 315,499,000 302,637,000 193,921,000 112,611,000  
      total stockholders' equity
    		             773,792,000 654,302,000 545,361,000 453,616,000 333,141,000 209,756,000  
      total liabilities and stockholders' equity
    		             2,171,799,000 2,043,230,000 1,918,276,000 1,894,683,000 1,601,247,000 1,351,768,000  
      lease facility financing obligation, less current portion
    		                55,324,000 55,626,000 55,924,000 56,167,000 
      accumulated other comprehensive loss
    		                 -39,000 -42,000 -44,000 
      payable to related parties pursuant to a tax receivable agreement
    		                744,254,000 520,067,000 382,362,000 389,546,000 
      lease commitments
    		                    
      assets held for sale
    		                 125,034,000   
      liabilities related to assets held for sale
    		                 11,487,000   
      non-controlling interests
    		                 139,220,000 97,145,000 66,235,000 
      current portion of payable to related parties pursuant to tax receivable agreement
    		                  1,298,000  
      stockholders' equity
    		                    
      liabilities and stockholders'/member’s equity
    		                    
      stockholders' / member's equity
    		                    
      member’s equity
    		                    
      total stockholders' / member's equity attributable to maravai lifesciences holdings, inc.
    		                   88,511,000 
      total stockholders' / member’s equity
    		                   154,746,000 
      total liabilities and stockholders' / member’s equity
    		                   1,270,691,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.